Supported by a young partnership, this Düsseldorf law firm is a market leader for patent litigation. Although it does not reach the high case numbers of competitor Krieger Mes, ROP conducts more litigation than many other German litigation teams. The firm boasts a broader technical positioning than Krieger Mes, as the lawyers are seen in both high-level pharmaceuticals and mobile communications suits. ROP is only active here on the side of industry/originators. In the major patent battles, teamwork between the ROP partners is more consistent than in other boutiques – a competitive advantage in cross-border proceedings.
Pharmaceuticals and mobile communications litigation, strong international contacts.
The boutique is banking on its independence and close contacts in European litigation firms for the UPC. Intensifying good connections to British firms Bristows or Powell Gilbert would be a good move, as both are being wooed by other German firms.
Max von Rospatt, Thomas Musmann, Dr. Henrik Timmann, Hetti Hilge.
7 partners, 6 associates
Predominantly litigation and advice in IP and adjacent practice areas, such as pharma advertising law and antitrust. Clear focus on patent infringement proceedings. Trademarks and unfair competition.
Litigation: Samsung against Fipa; LG against Unwired Planet and WiLan (all regarding mobile communications); CSL Behring against Shire concerning HAE patent; Mundipharma regarding Targin; Biogen concerning Tecfidera; MSD regarding cancer immunotherapy; Aral/BP against Swedish Biofuels regarding E10 fuel; Rhodia concerning catalysts; Unilin regarding laminates; Magna/Lucas Industries regarding auto technology.